CA SE STUDY NO. 4
Continued from page 21
Figure 2. STEADYPD3.com and MJFF Mixed Media Outreach
March 2014
Podcast, (n=2043)
December 2014
Webinar, (n=1973)
1260
1238
October 2015
Podcast, (n=2035)
1058
734
537
262
Mar
2014
May
2014
Jul
2014
Sep
2014
Nov
2014
Jan
2015
No. of Views
2 per Mov. Avg.
(No. of Views)
October 2015
Webinar, (n=2035)
Mar
2015
May
2015
Jul
2015
Sep
2015
Nov
2015
316
Jan
2016
306
Mar
2016
May
2016
146
Jul
2016
Sep
2016
Nov
2016
Jan
2017
Figure 3. Referral Sources: Enrolled STEADY PD-III Volunteers
Minority Recruitment Activity 1
Site Website 1
ClinicalTrials.gov 1
Study Web Ad 2
Study Website 2
PSG Website 2
Online News/Blog/Other 2
Specialist 2
Event 3
Family or Friend 3
Primary Care Physician 3
Other 3
Number of Volunteers Enrolled
9
Self
16
MJFF Communication
42
Fox Trial FInder
99
Neurologist
222
Site Personnel
0
50
Conclusion
Involving stakeholders with a range of perspectives early on is
important for learning about constituent motivations and barriers
to participation. Taking this step at the beginning of a clinical
100
150
200
250
trial can help in the formation of a comprehensive recruitment
strategy allowing trial teams to reach a broader audience and
more diverse target population.
For more information on the recruitment efforts used in the STEADY-PD III trial, visit: https://content.iospress.com/download/journal-of-
parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199
22
Accelerating Clinical Trials: Best Practices for Recruitment and Retention